BDBM50606309 CHEMBL5206905

SMILES CC(C)NC[C@@H](C(=O)N1CCN(CC1)c1ncnc2NC(=O)C[C@@H](C)c12)c1ccc(Cl)cc1

InChI Key InChIKey=MTIVHEGAZSBQQQ-VQIMIIECSA-N

Data  11 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 11 hits for monomerid = 50606309   

TargetCytochrome P450 2D6(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50606309(CHEMBL5206905)
Affinity DataIC50: >5.00E+4nMAssay Description:Inhibition of CYP2D6 in human liver microsomes at 0.01 to 30 uM using dextromethorphan as substrate in presence of NADPH by UPLC-MS/MS analysisMore data for this Ligand-Target Pair
In DepthDetails PubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50606309(CHEMBL5206905)
Affinity DataIC50: >5.00E+4nMAssay Description:Inhibition of CYP2C19 in human liver microsomes at 0.01 to 30 uM using mephenytoin as substrate in presence of NADPH by UPLC-MS/MS analysisMore data for this Ligand-Target Pair
In DepthDetails PubMed
TargetRAC-alpha serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50606309(CHEMBL5206905)
Affinity DataIC50:  1.60nMAssay Description:Inhibition of recombinant AKT1 (104 to 480 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptide substrate incubated ...More data for this Ligand-Target Pair
In DepthDetails PubMed
TargetRAC-alpha serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50606309(CHEMBL5206905)
Affinity DataIC50:  1.60nMAssay Description:Inhibition of recombinant AKT1 (104 to 480 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptide substrate incubated ...More data for this Ligand-Target Pair
In DepthDetails PubMed
TargetRAC-beta serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50606309(CHEMBL5206905)
Affinity DataIC50:  24nMAssay Description:Inhibition of recombinant AKT2 (120 to 481 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptide substrate incubated ...More data for this Ligand-Target Pair
In DepthDetails PubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50606309(CHEMBL5206905)
Affinity DataIC50:  3.92E+4nMAssay Description:Inhibition of CYP3A4 in human liver microsomes at 0.01 to 30 uM using phenacetin as substrate in presence of NADPH by UPLC-MS/MS analysisMore data for this Ligand-Target Pair
In DepthDetails PubMed
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50606309(CHEMBL5206905)
Affinity DataIC50:  0.300nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
In DepthDetails PubMed
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50606309(CHEMBL5206905)
Affinity DataIC50:  0.200nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
In DepthDetails PubMed
TargetCytochrome P450 1A2(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50606309(CHEMBL5206905)
Affinity DataIC50:  2.52E+4nMAssay Description:Inhibition of CYP1A2 in human liver microsomes at 0.01 to 30 uM using phenacetin as substrate in presence of NADPH by UPLC-MS/MS analysisMore data for this Ligand-Target Pair
In DepthDetails PubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50606309(CHEMBL5206905)
Affinity DataIC50: >5.00E+4nMAssay Description:Inhibition of CYP2C9 in human liver microsomes at 0.01 to 30 uM using diclofenac as substrate in presence of NADPH by UPLC-MS/MS analysisMore data for this Ligand-Target Pair
In DepthDetails PubMed
TargetRAC-beta serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50606309(CHEMBL5206905)
Affinity DataIC50:  40nMAssay Description:Inhibition of recombinant AKT2 (120 to 481 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptide substrate incubated ...More data for this Ligand-Target Pair
In DepthDetails PubMed